Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

Currently, SARS-CoV-2, especially the Omicron strain, is ravaging the world and even co-infecting human beings with IAV, which is a serious threat to human public health. As of yet, no specific antiviral drug has been discovered for SARS-CoV-2. This requires deeper understandings of the molecular me...

Full description

Bibliographic Details
Main Authors: Na Chen, Baoge Zhang, Lulu Deng, Bing Liang, Jihui Ping
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
IAV
SARS-CoV-2
virus-host interactions
replication cycle
host innate immunity
antiviral drug targets
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2071175

Similar Items

Similar Items